AL
SUPN icon

Airain Ltd’s Supernus Pharmaceuticals SUPN Stock Holding History

Airain Ltd’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-21,551
Closed -$290K – 1049
2015
Q4 		$290K Buy
+21,551
New +$333K 0.02% 617
2015
Q2 		– Sell
-39,044
Closed -$472K – 1071
2015
Q1 		$472K Buy
+39,044
New +$369K 0.03% 508
2014
Q4 		– Sell
-40,572
Closed -$353K – 898
2014
Q3 		$353K Buy
40,572
+5,229
+15% +$47.2K 0.02% 542
2014
Q2 		$387K Sell
35,343
-16,052
-31% -$143K 0.03% 473
2014
Q1 		$459K Buy
+51,395
New +$473K 0.08% 369

Other funds holding SUPN

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return

Airain Ltd's SUPN Position: Q1 2016 in Review

Airain Ltd sold out of Supernus Pharmaceuticals (SUPN) in Q1 2016, closing a stake of 21,551 shares — an estimated $290K sold.

Airain Ltd first reported a position in SUPN in Q1 2014 and held it in 5 quarters. The position peaked at $472K in Q1 2015. 213 funds tracked by Wall St. Rank hold SUPN as of Q1 2016.

  • Airain Ltd reported no remaining Supernus Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Airain Ltd sold 21,551 Supernus Pharmaceuticals shares in Q1 2016, an estimated $290K.
  • Airain Ltd first reported a position in Supernus Pharmaceuticals in Q1 2014 and held it in 5 quarters.
  • Airain Ltd's Supernus Pharmaceuticals position peaked at $472K in Q1 2015.
  • 213 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2016.

Based on Airain Ltd's 13F filing for Q1 2016, filed 9 May 2016.